This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: H. Lundbeck A/s. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Andreas Michael Arnold: Innovator in Orexin Receptor Agonists
Introduction
Andreas Michael Arnold is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target orexin receptors. His work is essential in advancing treatments for various conditions related to sleep and appetite regulation.
Latest Patents
Arnold holds a patent for "Spiromacrocyclic orexin 2 receptor agonists." This invention relates to novel spiro-macrocyclic compounds of general formula (I), which function as Orexin 2 receptor agonists. The patent highlights the potential of these compounds in therapeutic applications.
Career Highlights
Andreas Michael Arnold is associated with H. Lundbeck A/S, a prominent pharmaceutical company known for its focus on brain diseases. His role at Lundbeck has allowed him to contribute to innovative research and development in the field of neuroscience.
Collaborations
Arnold has collaborated with notable colleagues, including Erhad Ascic and Henrik Juhani Keränen. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Andreas Michael Arnold's work in developing orexin receptor agonists represents a significant advancement in pharmacological research. His contributions continue to influence the field and hold promise for future therapeutic innovations.